Predicting the Functional Effect of Amino Acid Substitutions and Indels
Open accessAbstract
As next-generation sequencing projects generate massive genome-wide sequence variation data, bioinformatics tools are being developed to provide computational predictions on the functional effects of sequence variations and narrow down the search of casual variants for disease phenotypes. Different classes of sequence variations at the nucleotide level are involved in human diseases, including substitutions, insertions, deletions, frameshifts, and non-sense mutations. Frameshifts and non-sense mutations are likely to cause a negative effect on protein function. Existing prediction tools primarily focus on studying the deleterious effects of single amino acid substitutions through examining amino acid conservation at the position of interest among related sequences, an approach that is not directly applicable to insertions or deletions. Here, we introduce a versatile alignment-based score as a new metric to predict the damaging effects of variations not limited to single amino acid substitutions but also in-frame insertions, deletions, and multiple amino acid substitutions. This alignment-based score measures the change in sequence similarity of a query sequence to a protein sequence homolog before and after the introduction of an amino acid variation to the query sequence. Our results showed that the scoring scheme performs well in separating disease-associated variants (n = 21,662) from common polymorphisms (n = 37,022) for UniProt human protein variations, and also in separating deleterious variants (n = 15,179) from neutral variants (n = 17,891) for UniProt non-human protein variations. In our approach, the area under the receiver operating characteristic curve (AUC) for the human and non-human protein variation datasets is ∼0.85. We also observed that the alignment-based score correlates with the deleteriousness of a sequence variation. In summary, we have developed a new algorithm, PROVEAN (Protein Variation Effect Analyzer), which provides a generalized approach to predict the functional effects of protein sequence variations including single or multiple amino acid substitutions, and in-frame insertions and deletions. The PROVEAN tool is available online at http://provean.jcvi.org.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Most in-silico tools tend to have low specificity, over-predict missense changes as deleterious, and are not as reliable at predicting missense variants with a milder effect.
“Most tools also tend to have low specificity, resulting in over-prediction of missense changes as deleterious and are not as reliable at predicting missense variants with a milder effect, 18”
From Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (2015) · cites this paper as [18]
In Results, Table 5 reports lower specificity than sensitivity for the three comparison tools on single-amino-acid substitutions, consistent with some neutral variants being predicted as deleterious. But the paper compares only three other tools, and its binary performance results do not establish that tools are less reliable specifically for missense variants with milder effects. No page numbers are available in our copy. (LLM, conf=0.84)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
A method and server for predicting damaging missense mutations.
Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., Kondrashov, A. S., & Sunyaev, S. R. (2010) · Nature Methods · doi:10.1038/nmeth0410-248 · Cited by 13,194 · see citing works
Needleman, S. B., & Wunsch, C. D. (1970) · Journal of Molecular Biology · doi:10.1016/0022-2836(70)90057-4 · Cited by 11,288 · see citing works
A map of human genome variation from population-scale sequencing.
The 1000 Genomes Project Consortium (2010) · Nature · doi:10.1038/nature09534 · Cited by 7,877 · see citing works
Integrating common and rare genetic variation in diverse human populations
The International HapMap 3 Consortium (2010) · Nature · doi:10.1038/nature09298 · Cited by 3,026 · see citing works
Targeted capture and massively parallel sequencing of 12 human exomes
Ng, S. B., Turner, E. H., Robertson, P. D., Flygare, S. D., Bigham, A. W., Lee, C., Shaffer, T., Wong, M., Bhattacharjee, A., Eichler, E. E., et al. (2009) · Nature · doi:10.1038/nature08250 · Cited by 2,030 · see citing works
Petitjean, A., Mathe, E., Kato, S., Ishioka, C., Tavtigian, S. V., Hainaut, P., & Olivier, M. (2007) · Human Mutation · doi:10.1002/humu.20495 · Cited by 1,598 · cited 1× · see citing works
“For the human tumor suppressor protein TP53, a set of 2,314 single point mutants and corresponding biological activity levels were obtained from the IARC TP53 database [33].”
MethodThe Human Gene Mutation Database: 2008 update
Stenson, P. D., Mort, M., Ball, E. V., Howells, K., Phillips, A. D., Thomas, N. S., & Cooper, D. N. (2009) · Genome Medicine · doi:10.1186/gm13 · Cited by 873 · see citing works
Flagged first, then by citations
Research works printed but not linked: 28
- [3]Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061– 1068. 18772890 PMC2671642
- [4]Ng PC, Levy S, Huang J, Stockwell TB, Walenz BP, et al (2008) Genetic variation in an individual human exome. PLoS Genet 4: e1000160. 18704161 PMC2493042
- [5]Ng PC, Henikoff S (2001) Predicting deleterious amino acid substitutions. Genome Res 11: 863– 874. 11337480 PMC311071
- [7]Reva B, Antipin Y, Sander C (2011) Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res 39: e118. 21727090 PMC3177186
- [8]Stone EA, Sidow A (2005) Physicochemical constraint violation by missense substitutions mediates impairment of protein function and disease severity. Genome Res 15: 978– 986. 15965030 PMC1172042
- [9]Thomas PD, Campbell MJ, Kejariwal A, Mi H, Karlak B, et al (2003) PANTHER: a library of protein families and subfamilies indexed by function. Genome Res 13: 2129– 2141. 12952881 PMC403709
- [10]Clifford RJ, Edmonson MN, Nguyen C, Buetow KH (2004) Large-scale analysis of non-synonymous coding region single nucleotide polymorphisms. Bioinformatics 20: 1006– 1014. 14751981
- [11]Gonzalez-Perez A, Lopez-Bigas N (2011) Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. Am J Hum Genet 88: 440– 449. 21457909 PMC3071923
- [12]Ng PC, Henikoff S (2006) Predicting the effects of amino acid substitutions on protein function. Annu Rev Genomics Hum Genet 7: 61– 80. 16824020
- [13]Cooper GM, Shendure J (2011) Needles in stacks of needles: finding disease-causal variants in a wealth of genomic data. Nat Rev Genet 12: 628– 640. 21850043
- [14]Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, et al (1989) Identification of the cystic fibrosis gene: genetic analysis. Science 245: 1073– 1080. 2570460
- [15]Kerem E, Corey M, Kerem B-s, Rommens J, Markiewicz D, et al (1990) The Relation between Genotype and Phenotype in Cystic Fibrosis — Analysis of the Most Common Mutation (ΔF508). New England Journal of Medicine 323: 1517– 1522. 2233932
- [16]Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, et al (2003) Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat 21: 577– 581. 12754702
- [18]Kato S, Han SY, Liu W, Otsuka K, Shibata H, et al (2003) Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proc Natl Acad Sci U S A 100: 8424– 8429. 12826609 PMC166245
- [19]Brunham LR, Singaraja RR, Pape TD, Kejariwal A, Thomas PD, et al (2005) Accurate prediction of the functional significance of single nucleotide polymorphisms and mutations in the ABCA1 gene. PLoS Genet 1: e83. 16429166 PMC1342637
- [21]Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, et al (1999) Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 22: 231– 238. 10391209
- [22]Grant JR, Arantes AS, Liao X, Stothard P (2011) In-depth annotation of SNPs arising from resequencing projects using NGS-SNP. Bioinformatics 27: 2300– 2301. 21697123 PMC3150039
- [23]Vilella AJ, Severin J, Ureta-Vidal A, Heng L, Durbin R, et al (2009) EnsemblCompara GeneTrees: Complete, duplication-aware phylogenetic trees in vertebrates. Genome Res 19: 327– 335. 19029536 PMC2652215
- [24]Dessimoz C, Cannarozzi G, Gil M, Margadant D, Roth A, et al.. (2005) OMA, A Comprehensive, Automated Project for the Identification of Orthologs from Complete Genome Data: Introduction and First Achievements Comparative Genomics. In: McLysaght A, Huson D, editors. Comparative Genomics. Berlin: Springer. pp. 61–72.
- [25]O'Roak BJ, Deriziotis P, Lee C, Vives L, Schwartz JJ, et al (2011) Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet 43: 585– 589. 21572417 PMC3115696
- [26]Ng SB, Bigham AW, Buckingham KJ, Hannibal MC, McMillin MJ, et al (2010) Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet 42: 790– 793. 20711175 PMC2930028
- [27]Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, et al (2010) Exome sequencing identifies the cause of a mendelian disorder. Nat Genet 42: 30– 35. 19915526 PMC2847889
- [28]Choi M, Scholl UI, Ji W, Liu T, Tikhonova IR, et al (2009) Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc Natl Acad Sci U S A 106: 19096– 19101. 19861545 PMC2768590
- [29]Erlich Y, Edvardson S, Hodges E, Zenvirt S, Thekkat P, et al (2011) Exome sequencing and disease-network analysis of a single family implicate a mutation in KIF1A in hereditary spastic paraparesis. Genome Res 21: 658– 664. 21487076 PMC3083082
- [31]Wildeman M, van Ophuizen E, den Dunnen JT, Taschner PE (2008) Improving sequence variant descriptions in mutation databases and literature using the Mutalyzer sequence variation nomenclature checker. Hum Mutat 29: 6– 13. 18000842
- [32]Markiewicz P, Kleina LG, Cruz C, Ehret S, Miller JH (1994) Genetic studies of the lac repressor. XIV. Analysis of 4000 altered Escherichia coli lac repressors reveals essential and non-essential residues, as well as “spacers” which do not require a specific sequence. J Mol Biol 240: 421– 433. 8046748
- [34]Li W, Godzik A (2006) Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics 22: 1658– 1659. 16731699
- [35]Styczynski MP, Jensen KL, Rigoutsos I, Stephanopoulos G (2008) BLOSUM62 miscalculations improve search performance. Nat Biotechnol 26: 274– 275. 18327232
Cited by
Sorted by citations
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594 · see citing works
Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway
Li, Z., Razavi, P., Li, Q., Toy, W., Liu, B., Ping, C., Hsieh, W., Sanchez-Vega, F., Brown, D. N., Da Cruz Paula, A. F., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.11.006 · Cited by 508 · see citing works
Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia
Genovese, G., Fromer, M., Stahl, E. A., Ruderfer, D. M., Chambert, K., Landén, M., Moran, J. L., Purcell, S. M., Sklar, P., Sullivan, P. F., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4402 · Cited by 444 · see citing works
The impact of low-frequency and rare variants on lipid levels
ENGAGE Consortium, Surakka, I., Horikoshi, M., Mägi, R., Sarin, A.-P., Mahajan, A., Lagou, V., Marullo, L., Ferreira, T., Miraglio, B., et al. (2015) · Nature Genetics · doi:10.1038/ng.3300 · Cited by 351 · see citing works
Montague, M. J., Li, G., Gandolfi, B., Khan, R., Aken, B. L., Searle, S. M. J., Minx, P., Hillier, L. W., Koboldt, D. C., Davis, B. W., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410083111 · Cited by 340 · see citing works
Cang, Z., & Wei, G.-W. (2017) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1005690 · Cited by 330 · see citing works
Protein design and variant prediction using autoregressive generative models
Shin, J.-E., Riesselman, A. J., Kollasch, A. W., McMahon, C., Simon, E., Sander, C., Manglik, A., Kruse, A. C., & Marks, D. S. (2021) · Nature Communications · doi:10.1038/s41467-021-22732-w · Cited by 320 · see citing works
The genetic basis of parental care evolution in monogamous mice
Bendesky, A., Kwon, Y.-M., Lassance, J.-M., Lewarch, C. L., Yao, S., Peterson, B. K., He, M. X., Dulac, C., & Hoekstra, H. E. (2017) · Nature · doi:10.1038/nature22074 · Cited by 268 · see citing works
Kortüm, K. M., Mai, E. K., Hanafiah, N. H., Shi, C.-X., Zhu, Y.-X., Bruins, L., Barrio, S., Jedlowski, P., Merz, M., Xu, J., et al. (2016) · Blood · doi:10.1182/blood-2016-02-698092 · Cited by 255 · see citing works
Zhang, L., Dong, X., Lee, M., Maslov, A. Y., Wang, T., & Vijg, J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1902510116 · Cited by 222 · see citing works
Evaluation of in silico algorithms for use with ACMG/AMP clinical variant interpretation guidelines
Ghosh, R., Oak, N., & Plon, S. E. (2017) · Genome biology · doi:10.1186/s13059-017-1353-5 · Cited by 233 · see citing works
Genetic Costs of Domestication and Improvement
Moyers, B. T., Morrell, P. L., & McKay, J. K. (2018) · Journal of Heredity · doi:10.1093/jhered/esx069 · Cited by 216 · see citing works
Jamialahmadi, O., Mancina, R. M., Ciociola, E., Tavaglione, F., Luukkonen, P. K., Baselli, G., Malvestiti, F., Thuillier, D., Raverdy, V., Männistö, V., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.12.023 · Cited by 148 · see citing works
Genetics of schizophrenia in the South African Xhosa
Gulsuner, S., Stein, D. J., Susser, E. S., Sibeko, G., Pretorius, A., Walsh, T., Majara, L., Mndini, M. M., Mqulwana, S. G., Ntola, O. A., et al. (2020) · Science · doi:10.1126/science.aay8833 · Cited by 118 · see citing works
Cadieux-Dion, M., Turcotte-Gauthier, M., Noreau, A., Martin, C., Meloche, C., Gravel, M., Drouin, C. A., Rouleau, G. A., Nguyen, D. K., & Cossette, P. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.6337 · Cited by 124 · see citing works
Variants in saposin D domain of prosaposin gene linked to Parkinson’s disease
Oji, Y., Hatano, T., Ueno, S.-I., Funayama, M., Ishikawa, K.-I., Okuzumi, A., Noda, S., Sato, S., Satake, W., Toda, T., et al. (2020) · Brain · doi:10.1093/brain/awaa064 · Cited by 116 · see citing works
MutaBind estimates and interprets the effects of sequence variants on protein–protein interactions
Li, M., Simonetti, F. L., Goncearenco, A., & Panchenko, A. R. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw374 · Cited by 118 · see citing works
The mitochondrial‐derived peptide <scp>MOTS</scp> ‐c: a player in exceptional longevity?
Fuku, N., Pareja‐Galeano, H., Zempo, H., Alis, R., Arai, Y., Lucia, A., & Hirose, N. (2015) · Aging Cell · doi:10.1111/acel.12389 · Cited by 98 · see citing works
Vockley, C. M., Guo, C., Majoros, W. H., Nodzenski, M., Scholtens, D. M., Hayes, M. G., Lowe, W. L., & Reddy, T. E. (2015) · Genome Research · doi:10.1101/gr.190090.115 · Cited by 99 · see citing works
Santos-Cortez, R. L. P., Lee, K., Giese, A. P., Ansar, M., Amin-Ud-Din, M., Rehn, K., Wang, X., Aziz, A., Chiu, I., Hussain Ali, R., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu042 · Cited by 58 · see citing works
Documentation of an Imperative To Improve Methods for Predicting Membrane Protein Stability
Kroncke, B. M., Duran, A. M., Mendenhall, J. L., Meiler, J., Blume, J. D., & Sanders, C. R. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00537 · Cited by 50 · see citing works
Park, J., Jekarl, D. W., Kim, Y., Kim, J., Kim, M., & Park, Y. M. (2015) · The Journal of Dermatology · doi:10.1111/1346-8138.12935 · Cited by 50 · see citing works
A mutation in the major autophagy gene, WIPI2, associated with global developmental abnormalities
Jelani, M., Dooley, H. C., Gubas, A., Mohamoud, H. S. A., Khan, M. T. M., Ali, Z., Kang, C., Rahim, F., Jan, A., Vadgama, N., et al. (2019) · Brain · doi:10.1093/brain/awz075 · Cited by 48 · see citing works
Bonnet-Brilhault, F., Alirol, S., Blanc, R., Bazaud, S., Marouillat, S., Thépault, R.-A., Andres, C. R., Lemonnier, É., Barthélémy, C., Raynaud, M., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.75 · Cited by 41 · see citing works
An ABCA4 loss-of-function mutation causes a canine form of Stargardt disease
Mäkeläinen, S., Gòdia, M., Hellsand, M., Viluma, A., Hahn, D., Makdoumi, K., Zeiss, C. J., Mellersh, C., Ricketts, S. L., Narfström, K., et al. (2019) · PLOS Genetics · doi:10.1371/journal.pgen.1007873 · Cited by 41 · see citing works
Katsumata, Y., Nelson, P. T., Estus, S., & Fardo, D. W. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.10.017 · Cited by 30 · see citing works
Defects in fatty acid amide hydrolase 2 in a male with neurologic and psychiatric symptoms
Sirrs, S., van Karnebeek, C. D., Peng, X., Shyr, C., Tarailo-Graovac, M., Mandal, R., Testa, D., Dubin, D., Carbonetti, G., Glynn, S. E., et al. (2015) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-015-0248-3 · Cited by 28 · see citing works
Elliot, M. G., & Crespi, B. J. (2015) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2014.0069 · Cited by 26 · see citing works
Mild nasal clefting may be predictive for <i>ALX4</i> heterozygotes
Altunoglu, U., Satkın, B., Uyguner, Z. O., & Kayserili, H. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36578 · Cited by 18 · see citing works
The impact of <i>SOCS1</i> mutations in diffuse large B‐cell lymphoma
Mellert, K., Martin, M., Lennerz, J. K., Lüdeke, M., Staiger, A. M., Kreuz, M., Löffler, M., Schmitz, N., Trümper, L., Feller, A. C., et al. (2019) · British Journal of Haematology · doi:10.1111/bjh.16147 · Cited by 17 · see citing works
Further delineation of putative <i>ACTB</i> loss‐of‐function variants: A 4‐patient series
Baumann, M., Beaver, E. M., Palomares‐Bralo, M., Santos‐Simarro, F., Holzer, P., Povysil, G., Müller, T., Valovka, T., & Janecke, A. R. (2020) · Human Mutation · doi:10.1002/humu.23970 · Cited by 16 · see citing works
Zheng, F., Jiang, X., Wen, Y., Yang, Y., & Li, M. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.12.018 · Cited by 14 · see citing works
- Authors
- Choi, Y., Sims, G. E., Murphy, S., Miller, J. R., & Chan, A. P.
- Affiliations
- J. Craig Venter Institute (US)
- Corresponding author
- Chan, Agnes P.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-10-08
- Volume
- 7
- Issue
- 10
- Pages
- e46688
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3466303
- OpenAlex
- W2089335658
- Cited by
- 2,890
- References
- 7
- Citations by year
- 2026: 80 · 2025: 123 · 2024: 139 · 2023: 205 · 2022: 280 · 2021: 338 · 2020: 284 · 2019: 310 · 2018: 261 · 2017: 228 · 2016: 214 · 2015: 213 · 2014: 160 · 2013: 52 · 2012: 1
- FWCI
- 82.10
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- National Human Genome Research Institute (R01HG004701)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- PROVEAN, protein sequence variation, amino acid substitutions, deleterious variant prediction, disease-associated variants, polymorphism, frameshift mutation, protein function prediction
- MeSH terms
- Animals, Humans, Mutation, Genome, Human, Computational Biology, Amino Acid Substitution, Databases, Genetic, INDEL Mutation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review